Literature DB >> 15175354

Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice.

Natalie K Schiller1, Audrey S Black, Gary P Bradshaw, David J Bonnet, Linda K Curtiss.   

Abstract

Lystbeige (beige) mice crossed with LDL receptor-deficient (LDLr-/-) mice had a distinct atherosclerotic lesion morphology that was not observed in LDLr-/- mice. This morphology is often associated with a stable plaque phenotype. We hypothesized that macrophage expression of the beige mutation accounted for this distinct morphology. Cultured bone marrow-derived macrophages from LDLr-/- and beige,LDLr-/- mice were compared for their ability to accumulate cholesterol, efflux cholesterol, migrate in response to chemotactic stimuli through Matrigel-coated membranes, and express matrix metalloproteinase 9 (MMP9). No differences in cholesterol metabolism were identified. Beige,LDLr-/- macrophage invasion in vitro appeared to be less than LDLr-/- macrophage invasion but did not achieve significance. Nevertheless, tumor necrosis factor-alpha-induced MMP9 expression, secretion, and enzymatic activity of beige,LDLr-/- macrophages were all significantly decreased compared with those of LDLr-/- macrophages (P < 0.05). For in vivo analyses of macrophage function, bone marrow transplantation (BMT) studies were performed. LDLr-/- mice and beige,LDLr-/- mice were irradiated and reconstituted with wild-type or beige bone marrow from mice expressing green fluorescent protein (GFP). Identification of GFP cells provided for direct identification of donor-derived cells within lesions. Only expression of the beige mutation in the BMT recipients altered the macrophage location and collagen content of the lesions. These results suggested that impaired macrophage function by itself did not account for the stable lesion morphology of beige,LDLr-/- double-mutant mice. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175354     DOI: 10.1194/jlr.M400036-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice.

Authors:  Gary Bradshaw; Alejandra Gutierrez; Jon H Miyake; Kimberly R Davis; Andrew C Li; Christopher K Glass; Linda K Curtiss; Roger A Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

2.  Modulation of atherosclerosis in mice by Toll-like receptor 2.

Authors:  Adam E Mullick; Peter S Tobias; Linda K Curtiss
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

3.  Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists.

Authors:  Linda K Curtiss; Audrey S Black; David J Bonnet; Peter S Tobias
Journal:  J Lipid Res       Date:  2012-07-20       Impact factor: 5.922

4.  Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.

Authors:  Tomoyuki Yasuda; Didier Grillot; Jeffery T Billheimer; François Briand; Philippe Delerive; Stephane Huet; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-28       Impact factor: 8.311

5.  The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice.

Authors:  M Rachel Richards; Audrey S Black; David J Bonnet; Grant D Barish; Connie W Woo; Ira Tabas; Linda K Curtiss; Peter S Tobias
Journal:  Innate Immun       Date:  2012-05-25       Impact factor: 2.680

6.  Chitinase inhibition promotes atherosclerosis in hyperlipidemic mice.

Authors:  Shiro Kitamoto; Kensuke Egashira; Toshihiro Ichiki; Xinbing Han; Sara McCurdy; Shohei Sakuda; Kenji Sunagawa; William A Boisvert
Journal:  Am J Pathol       Date:  2013-05-15       Impact factor: 4.307

7.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

8.  Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages.

Authors:  Xuewei Zhu; Ji-Young Lee; Jenelle M Timmins; J Mark Brown; Elena Boudyguina; Anny Mulya; Abraham K Gebre; Mark C Willingham; Elizabeth M Hiltbold; Nilamadhab Mishra; Nobuyo Maeda; John S Parks
Journal:  J Biol Chem       Date:  2008-06-14       Impact factor: 5.157

9.  Chronic Internal Exposure to Low Dose 137Cs Induces Positive Impact on the Stability of Atherosclerotic Plaques by Reducing Inflammation in ApoE-/- Mice.

Authors:  Clélia Le Gallic; Yohann Phalente; Line Manens; Isabelle Dublineau; Marc Benderitter; Yann Gueguen; Stephanie Lehoux; Teni G Ebrahimian
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

10.  Reduced size and macrophage content of advanced atherosclerotic lesions in mice with bone marrow specific deficiency of alpha 7 nicotinic acetylcholine receptor.

Authors:  Robert H Lee; Guillermo Vazquez
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.